Arkolith/Insider Trading/CNTX/Form 4/A

Dick Evan G.

SVP of R&DContext Therapeutics Inc. (CNTX) · full profile →Form 4/A · filed Dec 17, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 22, 2021Conversion(C)27K——83K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 22, 2021Conversion(C)27K——0

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001842952-21-000025) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML